2026-05-03 14:55:19
Latest Post
Mitsu Chem Plast Ltd Q4 FY2026 net profit climbs to Rs. 7.71 crores
L G Balakrishnan and Bros Ltd reports consolidated PAT of Rs. 69.72 crores in Q4 FY2026
Netweb Technologies India Ltd Q4 FY26 net profit at Rs. 70.59 crores
SMC Global Securities Ltd consolidated Q4FY26 net profit at Rs. 21.08 crores
Swastika Investmart Ltd Q4FY26 consolidated net profit at Rs. 2.88 crore
Stock Report
RPG Life Sciences Ltd Q4 FY2025-26 consolidated profit at Rs. 29.90 crores
Posted On : 2026-05-02 22:34:38( TIMEZONE : IST )
RPG Life Sciences Limited has reported Consolidated financial results for the period ended March 31, 2026.
Financial Results (Q4 FY2026) - QoQ Comparison
The company has reported total income of Rs. 189.29 crores during the period ended March 31, 2026 as compared to Rs. 183.44 crores during the period ended December 31, 2025.
The company has posted net profit / (loss) of Rs. 29.90 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs. 22.13 crores for the period ended December 31, 2025.
The company has reported EPS of Rs. 18.08 for the period ended March 31, 2026 as compared to Rs. 13.38 for the period ended December 31, 2025.
| Financials | Q4 FY2026 | Q3 FY2026 | % Change |
| Total Income | ₹ 189.29 crs | ₹183.44 crs |  3.19% |
| Net Profit | ₹29.90 crs | ₹22.13 crs | 35.11% |
| EPS | ₹18.08 | ₹13.38 | 35.13% |
Financial Results (Q4 FY2026) - YoY Comparison
The company has reported total income of Rs. 189.29 crores during the period ended March 31, 2026 as compared to Rs.148.15 crores during the period ended March 31, 2025.
The company has posted net profit / (loss) of Rs.29.90 crores for the period ended March 31, 2026 as against net profit / (loss) of Rs.117.35 crores for the period ended March 31, 2025.
The company has reported EPS of Rs.18.08 for the period ended March 31, 2026 as compared to Rs.70.96 for the period ended March 31, 2025.
| Financials | Q4 FY2026 | Q4 FY2025 | % Change |
| Total Income | ₹ 189.29 crs | ₹148.15 crs | 27.77% |
| Net Profit | ₹29.90 crs | ₹117.35 crs |  -74.52% |
| EPS | ₹18.08 | ₹70.96 | -74.52% |
Financial Results (Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.733.10 crores during the Financial Year ended March 31, 2026 as compared to Rs.666.11 crores during the Financial Year ended March 31, 2025.
The company has posted net profit / (loss) of Rs.115.17 crores for the Financial Year ended March 31, 2026 as against net profit / (loss) of Rs.183.24 crores for the Financial Year ended March 31, 2025.
The company has reported EPS of Rs.69.64 for the Financial Year ended March 31, 2026 as compared to Rs.110.80 for the Financial Year ended March 31, 2025.
| Financials | Year Ended FY2026 | Year Ended FY2025 | % Change |
| Total Income | ₹733.10 crs | ₹666.11 crs | 10.06% |
| Net Profit | ₹115.17 crs | ₹183.24 crs | -37.15% |
| EPS | ₹69.64 | ₹110.80 | -37.15% |
Shares of RPG Life Sciences Limited was last trading in BSE at Rs. 2022.50 as compared to the previous close of Rs. 2058.75. The total number of shares traded during the day was 704 in over 79 trades.
The stock hit an intraday high of Rs. 2068.50 and intraday low of 2016.35. The net turnover during the day was Rs. 1434908.00.
